These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8108876)

  • 21. In vivo immunosuppression by pan-T cell antibodies relates to their isotype and to their C1q uptake.
    Kummer U; Thierfelder S; Hoffmann-Fezer G; Schuh R
    J Immunol; 1987 Jun; 138(12):4069-74. PubMed ID: 2884259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitogenicity of anti-Thy-1 monoclonal antibodies attributable to an Fc-dependent mechanism.
    Kummer U; Haunschild J; Reisbach G; Delecluse HJ; Thierfelder S
    Eur J Immunol; 1993 Oct; 23(10):2649-54. PubMed ID: 8104797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of antibody isotype in IFN-gamma and IL-2 production during anti-CD3-induced T cell proliferation.
    Frenken LA; Koene RA; Tax WJ
    Transplantation; 1991 Apr; 51(4):881-7. PubMed ID: 1826571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunosuppression by Fc region-mismatched anti-T cell antibody treatment.
    Thierfelder S; Mocikat R; Mysliwietz J; Lindhofer H; Kremmer E
    Eur J Immunol; 1995 Aug; 25(8):2242-6. PubMed ID: 7664787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T-cell killing of target cells induced by hybrid antibodies: comparison of two bispecific monoclonal antibodies.
    Clark MR; Waldmann H
    J Natl Cancer Inst; 1987 Dec; 79(6):1393-401. PubMed ID: 3121901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of lethal graft-versus-host disease in mice by monoclonal antibodies directed to T cells or their subsets. II. Differential effectiveness of IgG2a and IgG2b isotypes of anti-CD3 and anti-CD4 moAb.
    Knulst AC; Noort WA; Tibbe GJ; Benner R; Savelkoul HF
    Bone Marrow Transplant; 1994 Oct; 14(4):535-43. PubMed ID: 7858528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoclonal antibodies for the prevention of graft-versus-host disease and marrow graft rejection. The depletion of T cell subsets in vitro and in vivo.
    Cobbold S; Martin G; Waldmann H
    Transplantation; 1986 Sep; 42(3):239-47. PubMed ID: 3529524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of T cell proliferation with anti-CD3 switch-variant monoclonal antibodies: effects of heavy chain isotype in monocyte-dependent systems.
    Van Lier RA; Boot JH; De Groot ER; Aarden LA
    Eur J Immunol; 1987 Nov; 17(11):1599-604. PubMed ID: 2960543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of lethal graft-versus-host disease in mice by monoclonal antibodies directed against T cells or their subsets. I. Evidence for the induction of a state of tolerance based on suppression.
    Knulst AC; Tibbe GJ; Noort WA; Bril-Bazuin C; Benner R; Savelkoul HF
    Bone Marrow Transplant; 1994 Mar; 13(3):293-301. PubMed ID: 8199571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Murine monoclonal IgG antibodies: differences in their IgG isotypes can affect the antibody effector activity when using human cells.
    Lobo PI; Patel HC
    Immunol Cell Biol; 1997 Jun; 75(3):267-74. PubMed ID: 9243292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improving the efficacy of antibody-interleukin 2 fusion proteins by reducing their interaction with Fc receptors.
    Gillies SD; Lan Y; Lo KM; Super M; Wesolowski J
    Cancer Res; 1999 May; 59(9):2159-66. PubMed ID: 10232603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Engineered antibodies of IgG1/IgG3 mixed isotype with enhanced cytotoxic activities.
    Natsume A; In M; Takamura H; Nakagawa T; Shimizu Y; Kitajima K; Wakitani M; Ohta S; Satoh M; Shitara K; Niwa R
    Cancer Res; 2008 May; 68(10):3863-72. PubMed ID: 18483271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological activity of human-mouse IgG1, IgG2, IgG3, and IgG4 chimeric monoclonal antibodies with antitumor specificity.
    Steplewski Z; Sun LK; Shearman CW; Ghrayeb J; Daddona P; Koprowski H
    Proc Natl Acad Sci U S A; 1988 Jul; 85(13):4852-6. PubMed ID: 3387441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new model for investigations of T-cell functions in mice: differential immunosuppressive effects of two monoclonal anti-Thy-1.2 antibodies.
    Opitz HG; Opitz U; Hewlett G; Schlumberger HD
    Immunobiology; 1982 Feb; 160(5):438-53. PubMed ID: 7040212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional polymorphisms of Fc receptors in human monocyte-mediated cytotoxicity towards erythrocytes induced by murine isotype switch variants.
    Boot JH; Geerts ME; Aarden LA
    J Immunol; 1989 Feb; 142(4):1217-23. PubMed ID: 2492577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoregulatory role of Ig isotypes. I. Induction of contrasuppressor T cells for contact sensitivity responses by antibodies of the IgM, IgG1, and IgG3 isotypes.
    Ptak W; Flood PM; Janeway CA; Marcinkiewicz J; Green DR
    J Immunol; 1988 Aug; 141(3):756-64. PubMed ID: 2456332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-specific differences in Fc gamma R effector functions.
    Xiu Y; Wong CP; Bouaziz JD; Hamaguchi Y; Wang Y; Pop SM; Tisch RM; Tedder TF
    J Immunol; 2008 Mar; 180(5):2863-75. PubMed ID: 18292508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A decrease in graft-vs.-host disease without loss of graft-vs.-leukemia reactivity after MHC-matched bone marrow transplantation by selective depletion of donor NK cells in vivo.
    Johnson BD; Truitt RL
    Transplantation; 1992 Jul; 54(1):104-12. PubMed ID: 1631918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation.
    Teshima T; Hill GR; Pan L; Brinson YS; van den Brink MR; Cooke KR; Ferrara JL
    J Clin Invest; 1999 Aug; 104(3):317-25. PubMed ID: 10430613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
    Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS
    Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.